Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
2016-02
2016-02
NCT00134056Uploaded 10-09-2021
Access via NCI by Request
PDS UID: nci-data-485
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Files: NCT00134056-D1![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT00134056-D1-Data-Dictionary_0.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT00134056-D1-Dataset_0.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf